Faculty Focus

 
The Kraft Precision Medicine Accelerator was established with an endowment from the Robert and Myra Kraft Family Foundation. Led by a diverse team of health care and business visionaries, the Accelerator leverages unique resources and world-renowned faculty. Kathy Giusti and Richard Hamermesh; co-chairs of the Kraft Precision Medicine Accelerator. 
 
BLAVATNIK FELLOWSHIP IN LIFE SCIENCE ENTREPRENEURSHIP is led by Professor Peter Barrett, and provides a select group of alumni with the opportunity to work with Harvard inventors to promote the commercialization of life science technologies with significant market potential. Fellows are part of the HBS Health Care Initiative and the vibrant entrepreneurial community at Harvard.
 

Featured Research

  • June 2017
  • Faculty Research

QuintilesIMS: Biosimilar Marketing in England

By: John A. Quelch and Emily C. Boudreau
  • 30 Mar 2017
  • Harvard Business School

Public Funding Essential for Advances in Biomedical Research

Re: Danielle Li
  • 12 Jan 2017
  • Harvard Business Review

What Cancer Researchers Can Learn from Direct-to-Consumer Companies

By: Kathy Giusti & Richard Hamermesh
  • 06 Jan 2016
  • Cold Call

A Microchip in Your Medicine

Re: Richard Hamermesh
  • January 2014 (Revised December 2014)
  • Faculty Research

GenapSys: Business Models for the Genome

By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
 

MBA Course

Commercializing Science: Technology Strategy & Business Models for Science-Based Enterprises

This course covers three main themes: technology strategy, business model design, and leadership, covering issues like managing risky technological bets, selecting and resourcing projects, building teams and managing scientists in a commercial setting, incentive design, intellectual property strategies, licensing and partnering, vertical integration decisions, and financing of science-based ventures. The course includes case materials from a broad array of science-based sectors, including biotechnology and pharmaceuticals, alternative energy and advanced materials.